目录
- Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective
- Evolving role of artificial intelligence in gastrointestinal endoscopy
- Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by hightemperatureprocessed feed in Sprague-Dawley rats
- Extrahepatic bile duct reconstruction in pigs with heterogenous animal-derived artificial bile ducts: A preliminary experience
- Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
- Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients
- Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domaincontaining 3 in active ulcerative colitis
- Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
- Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection
- Effect of postoperative early enteral nutrition on clinical outcomes and immune function of cholangiocarcinoma patients with malignant obstructive jaundice
- Value of shear wave elastography with maximal elasticity in differentiating benign and malignant solid focal liver lesions
- Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report